Evan Schwartz

Angel investor in Boston

Invests in AI

Evan Schwartz's investor profile lists AI alongside Healthcare & Biotech and Biotech & Pharma, at seed. The record holds 3 deals, among them VantAI, Psivant Therapeutics and 12 Labs.

Email Investor

Email Investor

Credits to line up before a seed round

Evan Schwartz backs companies at seed. A few of the larger credit programs on AI Perks for teams at that point:

Portfolio on record

Portfolio companies

  • VantAI
  • Psivant Therapeutics
  • 12 Labs

Investment focus

Backs startups in
Artificial Intelligence, Healthcare & Biotech, Biotech & Pharma
Rounds
Seed
Profile
Angel investor
Deals on record
3
Based in
Boston, United States

Ready to pitch AI investors?

AI Perks profiles show public professional information only, so there are no contact details here. Continue to find investors, send your pitch and track the replies.

Email Investor

Email Investor

More AI investors on AI Perks

Browse all AI investors

Questions founders ask

Does Evan Schwartz invest in AI startups?
Yes. Artificial Intelligence is one of the sectors on Evan Schwartz's investor profile, together with Healthcare & Biotech and Biotech & Pharma. The stages on record are seed.
Which companies has Evan Schwartz backed?
The record lists 3 deals, including VantAI, Psivant Therapeutics and 12 Labs. None of them has a perk listed on AI Perks yet.
What credits can a startup claim before pitching Evan Schwartz?
For a company raising a seed round, AI Perks lists credits such as Beefree SDK (up to $10,000), Mistral AI (up to $10,000), Deepgram (up to $100,000) and Oracle (up to $10,000), with each program's terms and how to apply.
Does AI Perks publish investor contact details?
No. AI Perks profiles show public professional information only: name, role, location, stages, sectors and the portfolio on record. To reach investors, continue with the Email Investor button below.Email Investor

Email Investor

Source: public professional information. Is this you? Request removal

Email Investor

Email Investor